The next Innovation Network Open Meeting will be on 4th March between 10:00-12.30

Scheduled for a day after the UK Budget there will be updates on business growth and innovation opportunities.   

Session will provide.

a) Update from national Industry and Government leaders on recovery and future plans

b) Clinical Leads for Innovation will share 2021/22 priorities for NHS and Social Care

c)  Investment partners will discuss how to improve access to support, funds and infrastructure to best capture domestic and international opportunities

d)  Hear from Scotland’s Clinicians, Academics and Industrialists on progress with the Cancer Diagnostics Moon Shot- 25 by 25- radical innovation in skin care

Registration here-

Draft Agenda 


Meeting Chair

Prof David Crossman Chief Scientist Officer

Scottish Government


Life Science Industry, Health and Social Care Update- Conversation

Mary McAllan Director of Economic Development Scottish Government

Tom Steele Chair NHS SAS and Co-Chair Innovation Steering Group

Christine McLaughlin Director of Planning Scottish  Government and Co-Chair Innovation Steering Group

Dave Tudor   Managing Director, Medicines Manufacturing Innovation Centre and Co-Chair Life Science Industry Leadership Group

Mary Jones (Deputy Director, Strategy, Investment, and Manufacturing) Office of Life Science UK Government

Richard Hebdon Life Sciences Lead Innovate UK


Chair Euan Dick Head of CSO


NHS and Social Care - Priorities for Innovation in Scotland

Exploring Partnership Opportunities-Conservation



Prof Graeme Houston, Dr David Low, Dr Neil Patel and Prof Tim Welsh- Scotland’s Leads for Innovation in Health and Social Care


Chair Colin MacBean Depute Director Economy


Investment-Creating the Optimum Investment Ecosystem for Rapid Growth


Shortening the Distance between Innovator and Customer-Conversation



Katrine Feldinger Capital Investment Scottish Government

Alan Petters and James Norman  Dell Bank International

Richard Higginson  Par Equity Investment Network

Duncan Moore Chair Scottish Life Science Association

Grahame Watson Scottish Health Innovation Ltd

James Blackwood iCaird

A. Sinclair Dunlop Managing Partner Venture Capital Epidarex (pre-recorded)

NVidia-Investment Partners

Gordon Beattie Director of National Procurement NHS


Chair Ian Campbell Life Arc


Diagnosing Cancer within 25 Days by 2025-moon-shot exploration

National Industry, NHS, Social Care and academia collaboration

Scotland’s Dermatology Consortium - Clinical and Industrial Leaders


Chair Prof David Harrison


Concluding Remarks

Prof David Crossman Chief Scientist Officer


Published on: 02 February 2021
Last Updated On: 11 February 2021